Quercetin for Blood Pressure: Serban, Huang & Popiolek-Kalisz Findings
Educational summary — not medical advice. Quercetin is associated with a modest blood-pressure reduction in trials at a specific dose — it is not a treatment for hypertension and not a substitute for prescribed medication. Don't stop or change a blood-pressure drug without your clinician. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
The honest answer
Quercetin's strongest, most-replicated evidence in this category. Three independent meta-analyses — Serban 2016 (7 RCTs), Huang 2020 (17 RCTs), Popiolek-Kalisz 2022 (10 RCTs) — each found a small but statistically significant systolic/diastolic reduction from plain quercetin, roughly 2–4.5 mmHg systolic. Serban's own dose-stratified data shows the effect clears significance only at 500 mg/day and up — below that, it was not significant. Larger in people who already run hypertensive or pre-hypertensive. A few mmHg, not a hypertension treatment, and not a reason to change your prescribed medication.
What the three meta-analyses show — and where they stop
These are three independent research groups, pooling overlapping but not identical sets of RCTs, publishing six years apart, and they agree on the same modest-sized effect:
| Study | What it pooled | Finding | The honest limit |
|---|---|---|---|
| Serban 2016 PMID 27405810 | 7 RCTs / 9 treatment arms, n=587 | SBP −3.04 mmHg overall (P=0.028); DBP −2.63 mmHg (P<0.001). Dose-stratified: ≥500mg/day SBP −4.45 mmHg (P=0.007) — significant. <500mg/day SBP −1.59 mmHg (P=0.273) — NOT significant. | The single most important number in this evidence base: the effect only clears significance at 500mg/day and up. |
| Huang 2020 PMID 31940027 | 17 RCTs, n=896 | SBP −3.09 mmHg, DBP −2.86 mmHg (both significant). No significant overall lipid effect; fasting glucose unchanged. | Broader, more heterogeneous trial pool than Serban's; authors note "conflicting results" in the underlying literature. |
| Popiolek-Kalisz 2022 PMID 35948195 | 10 RCTs, n=841 | SBP −2.38 mmHg mixed population (P=0.01); pre-hypertensive/hypertensive subgroup DBP −3.14 mmHg (P<0.00001) — larger effect at higher baseline BP. | Most recent of the three; reinforces Serban's "works better in people who already run high" pattern rather than adding an independent new signal. |
Read together: three independent groups, different but overlapping trial pools, agree that plain quercetin produces a small, real systolic/diastolic reduction, concentrated in people with elevated baseline blood pressure, and dependent on dose — Serban's data draws the line at 500 mg/day. The consistency across three separate meta-analyses is the strength of this evidence; the honest limit is that "a few mmHg" is a modest effect next to lifestyle interventions like sodium reduction or exercise, and nowhere near what a prescribed antihypertensive delivers.
The dose is the whole story Below 500 mg/day of plain quercetin, Serban 2016's own dose-stratified data found no statistically significant blood-pressure effect (P=0.273). A quercetin product dosed under 500 mg/day — including most phytosome products, which are dosed for a different outcome entirely — is not backed by this evidence for blood pressure specifically. See the dosage guide for the full plain-vs-phytosome breakdown.
Why the form matters here specifically
All three meta-analyses are built on trials using plain (unformulated) quercetin, not the phytosome form. Phytosome quercetin (Quercefit) absorbs far better per mg — up to 20 times higher plasma levels at the same labeled mg, per Riva 2019 — but no blood-pressure trial in this evidence base tested phytosome quercetin at any dose. That means a lower-mg phytosome product is not automatically "enough" for blood pressure just because it delivers more circulating quercetin per mg than a plain product; the trials that actually measured a BP outcome used plain quercetin at 500 mg/day and up, and that's the evidence-backed choice if blood pressure is specifically your goal. See best quercetin for plain-quercetin picks ranked by cost per mg.
Who this is most reasonable for
- People with elevated blood pressure — where the effect was clearest and largest across all three meta-analyses, as an adjunct to diet, exercise, and any care your clinician advises.
- People willing to take plain quercetin at 500 mg/day or more — the dose the significant findings are built on, not a smaller "maintenance" amount.
- As support, not a substitute — a modest few-mmHg effect complements, but doesn't replace, prescribed blood-pressure medication or lifestyle changes.
Talk to your clinician first if you take blood-pressure medication and are considering adding quercetin (don't change your prescription on your own), or if you take a quinolone antibiotic, anticoagulant, or another CYP-metabolized drug — quercetin can alter how these are processed.
Frequently asked questions
Does quercetin lower blood pressure?
Modestly — three independent meta-analyses agree on a small (2-4.5 mmHg systolic) reduction from plain quercetin, significant mainly at 500mg/day and up (Serban 2016). Not a hypertension treatment.
How much does quercetin lower blood pressure?
Roughly 2-4.5 mmHg systolic, 2-3 mmHg diastolic across the three meta-analyses — larger in people already hypertensive. A modest effect, not medication-level.
What dose do I need for blood pressure?
500mg/day or more of PLAIN quercetin — Serban 2016 found no significant effect below that dose. Phytosome doses (200-250mg) have not been tested for blood pressure.
Can quercetin replace my blood-pressure medication?
No. No trial used it as monotherapy replacing medication, and the effect size is far smaller than a prescribed antihypertensive. Never change your medication without your clinician.
Related
- Quercetin: what it is & who it's for
- Quercetin dosage guide — plain vs phytosome, with a dose checker
- Best quercetin — ranked by form, then cost per mg
- Does quercetin work? — the full honest verdict, including allergies and the absorption problem
Sources
- Serban C, et al. "Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials." J Am Heart Assoc. 2016. PMID: 27405810
- Huang H, et al. "Effects of quercetin supplementation on cardiovascular risk factors: a systematic review and meta-analysis." Nutr Rev. 2020. PMID: 31940027
- Popiolek-Kalisz J, Fornal E. "The Effects of Quercetin Supplementation on Blood Pressure." Curr Probl Cardiol. 2022. PMID: 35948195
- Riva A, et al. "Improved Oral Absorption of Quercetin from Quercetin Phytosome." Eur J Drug Metab Pharmacokinet. 2019. PMID: 30328058